Timely referrals for transplantation and left ventricular assist device implantation play a key
role in favorable outcomes in patients with advanced heart failure. Nonetheless, evaluation …

Dietary guidance for patients with heart failure (HF) has traditionally focused on sodium and
fluid intake restriction, but dietary quality is frequently poor in patients with HF and may …

Introduction Patients suffering from advanced heart failure may undergo left ventricular
assist device (LVAD) placement as a bridge to cardiac transplantation. However, those with …

Background Obesity is an epidemic that is closely associated with heart failure. The ultimate
treatment for end-stage heart failure is cardiac transplantation. Patients with morbid obesity …

Background Obesity remains a relative contraindication for heart transplantation, and hence,
obese patients with advanced heart failure receive ventricular assist devices (VADs) either …

Background There is limited data in the literature evaluating outcomes of bariatric surgery in
severely obese patients with left ventricular assist device (LVAD) as a bridge to make them …

BACKGROUND Limited data exist describing impact of body mass index (BMI) on post‒left
ventricular assist device (post-LVAD) outcomes. We sought to define the relationship …

Background Class II obesity (body mass index BMI≥ 35 kg/m 2) is a contraindication to
heart transplantation (HT). Although few single-center studies (case reports/series and small …

Background Severe cardiac disease often warrants intervention to improve cardiac function,
such as mechanical support via a left ventricular assist device (LVAD). While this is an …

Background As obesity prevalence grows, more end-stage organ disease patients will be
precluded from transplant. Numerous reports suggest bariatric surgery in end-stage organ …